Cargando…
Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives
Shiga toxins (Stx) are AB(5)-type toxins, composed of five B subunits which bind to Gb(3) host cell receptors and an active A subunit, whose action on the ribosome leads to protein synthesis suppression. The two Stx types (Stx1 and Stx2) and their subtypes can be produced by Shiga toxin-producing Es...
Autores principales: | Henrique, Izabella de Macedo, Sacerdoti, Flavia, Ferreira, Raissa Lozzardo, Henrique, Camila, Amaral, Maria Marta, Piazza, Roxane Maria Fontes, Luz, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866733/ https://www.ncbi.nlm.nih.gov/pubmed/35223548 http://dx.doi.org/10.3389/fcimb.2022.825856 |
Ejemplares similares
-
Human Recombinant Fab Fragment Neutralizes Shiga Toxin Type 2 Cytotoxic Effects in vitro and in vivo
por: Luz, Daniela, et al.
Publicado: (2018) -
The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody
por: Luz, Daniela, et al.
Publicado: (2021) -
Human Glomerular Endothelial Cells Treated With Shiga Toxin Type 2 Activate γδ T Lymphocytes
por: Rosso, David Antonio, et al.
Publicado: (2021) -
Treatment Strategies for Infections With Shiga Toxin-Producing Escherichia coli
por: Mühlen, Sabrina, et al.
Publicado: (2020) -
Editorial: Shiga toxin-producing Escherichia coli (STEC) infections and consequences
por: Goldstein, Jorge, et al.
Publicado: (2022)